OncBioMune Pharmaceuticals, Inc (174) | Uncategorized (31)
Recent Contracts
-
Offer Letter between the Company and Faith Zaslavsky, dated December 5, 2022
(Filed With SEC on December 9, 2022)
-
Form of 10% Original Issue Discount Senior Secured Convertible Debentures
(Filed With SEC on December 1, 2022)
-
Form of 10% Original Issue Discount Senior Secured Convertible Debentures (Exchanged Debentures)
(Filed With SEC on December 1, 2022)
-
Engagement Letter, by and between Carter, Terry & Company and Theralink Technologies, Inc., dated December 15, 2021, as amended
(Filed With SEC on February 3, 2022)
-
Form of Warrants issued September 24, 2018
(Filed With SEC on November 14, 2018)
-
Warrants Agreement between Cavalry I LP and OncBioMune, Inc, dated November 13, 2018
(Filed With SEC on November 14, 2018)
-
ForbearanceAgreement
(Filed With SEC on June 6, 2017)
-
NON-QUALIFIEDSTOCK OPTION AGREEMENT FOR DIRECTORS
(Filed With SEC on April 21, 2017)
-
PARTIES
(Filed With SEC on March 13, 2017)
-
Representations
(Filed With SEC on March 13, 2017)
-
STOCKHOLDERS’AGREEMENT datedas of March10, 2017 among ONCBIOMUNEPHARMACEUTICALS, INC. and THESTOCKHOLDERS PARTY HERETO
(Filed With SEC on March 13, 2017)
-
FORMOF
(Filed With SEC on March 13, 2017)
-
FORMOF NON-QUALIFIEDSTOCK OPTION AGREEMENT
(Filed With SEC on March 13, 2017)
-
AMENDEDAND RESTATED SECURITIESPURCHASE AGREEMENT
(Filed With SEC on November 28, 2016)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on November 21, 2016)
-
SABRCapital Management LLC 335 Madison Avenue, Suite 1100, New York, New York 10017
(Filed With SEC on May 16, 2016)
-
Account
(Filed With SEC on May 16, 2016)
-
EMPLOYMENTAGREEMENT
(Filed With SEC on February 5, 2016)
-
PURCHASEAGREEMENT
(Filed With SEC on November 20, 2015)
-
PURCHASEAGREEMENT
(Filed With SEC on October 26, 2015)
-
SHAREEXCHANGE AGREEMENT Dated June22, 2015 byand among QUINTMEDIA, INC., a Nevada Corporation asthe Acquiror and Parent. and ONCBIOMUNE,INC., aLouisiana corporation and...
(Filed With SEC on June 24, 2015)
-
DEBTSETTLEMENT AGREEMENT
(Filed With SEC on June 24, 2015)
-
DEBTSETTLEMENT AGREEMENT
(Filed With SEC on March 16, 2015)
-
Co-Promotion Agreement dated February 21, 2012 with Apricus Biosciences, Inc. (portions of the exhibit have been omitted pursuant to a request for confidential treatment)
(Filed With SEC on May 18, 2012)
-
Form of independent contractor agreement
(Filed With SEC on September 30, 2011)
-
Co-promotion agreement with Bi-Coastal Pharmaceuticals effective September 12, 2011 (portions of the exhibit have been omitted pursuant to a request for confidential treatment)
(Filed With SEC on September 14, 2011)
-
Lock-up Agreement dated February 9, 2011 with Cameron Durrant
(Filed With SEC on February 10, 2011)
-
Lock-up Agreement dated February 9, 2011 with David Tousley
(Filed With SEC on February 10, 2011)
-
Cancellation Agreement dated February 9, 2011 with Cameron Durrant
(Filed With SEC on February 10, 2011)
-
Cancellation Agreement dated February 9, 2011 with David Tousley
(Filed With SEC on February 10, 2011)
-
Letter of Intent with Granisol Oral Solution
(Filed With SEC on June 28, 2010)